Genmab — Marts 2011
-
making better spending decisions
-
nu kommer david
-
gennemgår regnskabet....
-
de er nu nede på 189 medarbejdere
-
de har undgået en emission som markedet var nervøse for og kommer derfor ud med mere cash i år end sidste
-
omkostninger er bedre end meldt ud
-
laveste underskud siden IPO
-
og bedre end guidance
-
Guidance nu for 2011
-
tight range for revenue
-
ingen milestones includerer ikke milestones
-
arzerra er svære at forudsige...and he honestly dont know what they will be
-
midpoint på 700 inkluderer 80 mill zalu
-
uden zalu er vi på 620
-
ok nu fik vi forklaringen på burn
-
midpoiunt af operating + tilbageførsel af deferred revenue på 226
-
ingen aftaler er indeholdt i guidance
-
2011 Objectives....
-
interessant slide
-
meet or beat guidance
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind